News

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...
Analysts are estimating that Progressive will report an earnings per share (EPS) of $4.29. Investors in Progressive are eagerly awaiting the company's announcement, hoping for news of surpassing ...
Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of ...
Pfizer has caught investors’ eyes recently, outperforming its peers slightly but facing modest growth prospects ahead.
Tuesday: JPMorgan Chase, Wells Fargo, Citigroup, BlackRock, and Bank of New York Mellon release results. Wednesday: Bank of ...
Zacks Investment Research on MSN23h
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
Pfizer (PFE) ended the recent trading session at $25.35, demonstrating a -1.17% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.14%.
NextEra (NEE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...